SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,041,000 | -90.7% | 20,649 | -94.5% | 0.02% | -94.0% |
| Q1 2020 | $43,299,000 | -50.1% | 375,275 | -50.6% | 0.35% | -22.8% |
| Q4 2019 | $86,738,000 | +38.9% | 759,130 | +3.8% | 0.46% | +19.1% |
| Q3 2019 | $62,426,000 | +35.8% | 730,989 | +10.1% | 0.38% | +59.6% |
| Q2 2019 | $45,955,000 | +1625.7% | 664,000 | +1726.2% | 0.24% | +1900.0% |
| Q1 2019 | $2,663,000 | -51.8% | 36,360 | -49.2% | 0.01% | -47.8% |
| Q3 2018 | $5,522,000 | -93.4% | 71,600 | -94.3% | 0.02% | -93.1% |
| Q2 2018 | $83,840,000 | +1250.3% | 1,262,848 | +952.4% | 0.34% | +857.1% |
| Q2 2017 | $6,209,000 | -79.0% | 120,000 | -74.4% | 0.04% | -78.8% |
| Q1 2017 | $29,521,000 | – | 469,625 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |